Posterior reversible encephalopathy syndrome in children with kidney diseases

Kenji Ishikura(Kitasato University), Masataka Honda(Rikkyo University), Yuko Hamasaki(Toho University), Tomoyuki Sakai(Tokyo Metropolitan Children's Medical Center), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Robert H. Mak(University of California San Diego)
Pediatric Nephrology
May 10, 2011
10.1007/s00467-011-1873-2
Cited by 63

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135